Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nervive Nerve Relief PM is an over-the-counter oral dietary supplement from Procter & Gamble marketed under the Nervive brand for occasional nerve discomfort associated with peripheral neuropathy symptoms such as stabbing, burning, and pins-and-needles sensations in the hands and feet. It is a multi-ingredient small-molecule nutraceutical product containing alpha lipoic acid 600 mg together with vitamins B1, B6, and B12, plus melatonin and an herbal blend including chamomile and lavender for nighttime use. Its intended rationale is supportive rather than disease-modifying: alpha lipoic acid is marketed for antioxidant support in nerve health, B vitamins support normal nerve function, and melatonin is included as a sleep aid to help users fall asleep naturally. The product is sold as a dietary supplement and is not an FDA-evaluated pharmaceutical for diagnosing, treating, curing, or preventing disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nervive Nerve Relief PM.